Novel Approaches To Quantifying Cardioprotective Medication Use in High-Risk Kidney Transplant Recipients

被引：0
|
作者：
Lentine, Krista [1 ]
Xiao, Huiling [1 ]
Schnitzler, Mark [1 ]
Abbott, Kevin
Salvalaggio, Paolo [2 ]
Axelrod, David
Brennan, Daniel [3 ]
机构：
[1] St Louis Univ, St Louis, MO 63103 USA
[2] Univ Washington, Seattle, WA 98195 USA
[3] Washington Univ, St Louis, MO 63130 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2010年 / 10卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：53 / 54
页数：2
相关论文
共 50 条
  • [21] Comparison of the efficacy of induction therapy between ethnicities in high-risk kidney transplant recipients
    Fleming, J. N.
    Weimert, N. A.
    Taber, D. J.
    Egidi, F. M.
    Ayiku, H.
    McGillicuddy, J.
    Bratton, C. F.
    Lin, A.
    Baliga, P. K.
    Chavin, K. D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 441 - 441
  • [22] Use of Adjuvant Sorafenib in Liver Transplant Recipients with High-Risk Hepatocellular Carcinoma
    Shetty, Kirti
    Dash, Chiranjeev
    Laurin, Jacqueline
    JOURNAL OF TRANSPLANTATION, 2014, 2014
  • [23] Chemoprevention of Skin Carcinomas in High-Risk Transplant Recipients
    Savoia, Paola
    Zavattaro, Elisa
    Cremona, Ottavio
    CURRENT MEDICINAL CHEMISTRY, 2018, 25 (06) : 687 - 697
  • [24] Informed Consent in High-Risk Renal Transplant Recipients
    Cocchiara, G.
    Lo Monte, A. I.
    Romano, G.
    Romano, M.
    Buscemi, G.
    TRANSPLANTATION PROCEEDINGS, 2009, 41 (05) : 1524 - 1526
  • [25] The Efficacy of Rituximab in High-risk Renal Transplant Recipients
    Araki, Motoo
    Wada, Koichiro
    Mitsui, Yosuke
    Kubota, Risa
    Yoshioka, Takashi
    Ariyoshi, Yuichi
    Kobayashi, Yasuyuki
    Kitagawa, Masashi
    Tanabe, Katsuyuki
    Sugiyama, Hiroshi
    Wada, Jun
    Watanabe, Masami
    Watanabe, Toyohiko
    Hotta, Katsuyuki
    Nasu, Yasutomo
    ACTA MEDICA OKAYAMA, 2016, 70 (04) : 295 - 297
  • [26] The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High-Risk Kidney Transplant Recipients
    Humar, A.
    Lebranchu, Y.
    Vincenti, F.
    Blumberg, E. A.
    Punch, J. D.
    Limaye, A. P.
    Abramowicz, D.
    Jardine, A. G.
    Voulgari, A. T.
    Ives, J.
    Hauser, I. A.
    Peeters, P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 (05) : 1228 - 1237
  • [27] Immunotherapy for Advanced Skin Cancer in Kidney Transplant Recipients-The High-Risk Balancing Act
    Stump, Madeliene
    Arron, Sarah
    Proby, Charlotte
    JAMA DERMATOLOGY, 2024, 160 (08) : 799 - 800
  • [28] Zenapax versus OKT-3 prophylaxis in immunologically high-risk kidney transplant recipients
    Lácha, J
    Símová, M
    Nosková, L
    Teplan, V
    Vítko, S
    TRANSPLANTATION PROCEEDINGS, 2001, 33 (03) : 2273 - 2274
  • [29] Primary low-dose tacrolimus immunosuppressive prophylaxis for high-risk kidney transplant recipients
    Braun, F
    Lorf, T
    Grupp, C
    Schütz, E
    Sattler, B
    Canelo, R
    Müller, GA
    Ringe, B
    TRANSPLANTATION PROCEEDINGS, 1998, 30 (04) : 1221 - 1223
  • [30] Budget Impact Analysis of Quantiferon-CMV Assay for High-risk Kidney Transplant Recipients
    Kotton, Camille N.
    Wu, Joanne
    Kuhr, Frank K.
    Nichol, Michael B.
    TRANSPLANTATION, 2016, 100 (07) : S480 - S480
12345